Immunization against potential biological warfare agents
- PMID: 10880299
- DOI: 10.1086/313812
Immunization against potential biological warfare agents
Abstract
The intentional release of biological agents by belligerents or terrorists is a possibility that has recently attracted increased attention. Law enforcement agencies, military planners, public health officials, and clinicians are gaining an increasing awareness of this potential threat. From a military perspective, an important component of the protective pre-exposure armamentarium against this threat is immunization. In addition, certain vaccines are an accepted component of postexposure prophylaxis against potential bioterrorist threat agents. These vaccines might, therefore, be used to respond to a terrorist attack against civilians. We review the development of vaccines against 10 of the most credible biological threats.
Similar articles
-
Viral vectors for use in the development of biodefense vaccines.Adv Drug Deliv Rev. 2005 Jun 17;57(9):1293-314. doi: 10.1016/j.addr.2005.01.011. Epub 2005 Apr 15. Adv Drug Deliv Rev. 2005. PMID: 15935875 Review.
-
DNA vaccines for biodefence.Adv Drug Deliv Rev. 2005 Jun 17;57(9):1343-61. doi: 10.1016/j.addr.2005.01.013. Epub 2005 Apr 13. Adv Drug Deliv Rev. 2005. PMID: 15935877 Review.
-
Adjusting FDA policies to address bioterrorist threat.Nat Biotechnol. 1999 Apr;17(4):323-4. doi: 10.1038/7873. Nat Biotechnol. 1999. PMID: 10207870 No abstract available.
-
Disease prevention by immunization and chemoprophylaxia.J Indiana State Med Assoc. 1975 Jun;68(6):462-6. J Indiana State Med Assoc. 1975. PMID: 1127246 No abstract available.
-
Biological agents with potential for misuse: a historical perspective and defensive measures.Toxicol Appl Pharmacol. 2004 Aug 15;199(1):71-84. doi: 10.1016/j.taap.2004.03.009. Toxicol Appl Pharmacol. 2004. PMID: 15289092 Review.
Cited by
-
Influence of glycosylation and oligomerization of vaccinia virus complement control protein on level and pattern of functional activity and immunogenicity.Protein Cell. 2010 Dec;1(12):1084-92. doi: 10.1007/s13238-010-0139-2. Epub 2011 Jan 8. Protein Cell. 2010. PMID: 21213103 Free PMC article.
-
Provider and health care system response to a bioterrorist attack.Proc (Bayl Univ Med Cent). 2001 Jul;14(3):224-30. doi: 10.1080/08998280.2001.11927767. Proc (Bayl Univ Med Cent). 2001. PMID: 16369621 Free PMC article. No abstract available.
-
Pulmonary Manifestations of Bioterrorism.Curr Infect Dis Rep. 2001 Jun;3(3):249-257. doi: 10.1007/s11908-001-0027-2. Curr Infect Dis Rep. 2001. PMID: 11384555
-
The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicle.Infect Immun. 2009 Feb;77(2):877-84. doi: 10.1128/IAI.01017-08. Epub 2008 Dec 1. Infect Immun. 2009. PMID: 19047401 Free PMC article.
-
Vaccine Advances against Venezuelan, Eastern, and Western Equine Encephalitis Viruses.Vaccines (Basel). 2020 Jun 3;8(2):273. doi: 10.3390/vaccines8020273. Vaccines (Basel). 2020. PMID: 32503232 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical